MRZLF
9/17/26

Mirasol Resources (MRZLF)

Thursday
12:05 PM
ThesisMirasol Resources: the story is balanced — Drill assay results from active exploration programs showing high-grade silver-gold intercepts

Revenue Outlook

What Moves the Stock

  1. 01Drill assay results from active exploration programs showing high-grade silver-gold intercepts
  2. 02Silver and gold spot prices - direct correlation as project valuations are NPV-sensitive to metal price assumptions
  3. 03Joint venture announcements with major mining companies providing validation and funding
  4. 04Geopolitical developments in Argentina affecting mining investment climate and currency stability
  5. 05Equity financing announcements and dilution concerns given cash burn rate
  6. 06No current revenue - pre-production exploration stage
  7. 07Potential future revenue from joint venture option payments and milestone fees
  8. 08Ultimate revenue contingent on project development or asset sale to major miners
FY2025 Snapshot
Revenue
$0.00
NI Growth
-12.1%
EPS
$-0.13
1Y Return
-26.7%

MRZLF Chart

0.20.30.30.40.40.22MRZLF Daily0.22Apr '26Jun '26Jul '26Sep '26

My Notes

  • momentum/speculative - Attracts retail investors and specialized resource funds seeking asymmetric returns from exploration success.
  • Rising interest rates are significantly negative for junior explorers through multiple channels: higher discount rates reduce NPV of future…
  • Watch on earnings: Silver spot price (SILUSD) - primary metal of focus for Argentine projects, Gold spot price (GCUSD) - secondary metal and portfolio diversification, Argentine peso exchange rate and capital control policies affecting operational costs.

One Sentence Summary:

Mirasol Resources: the story is balanced — drill assay results from active exploration programs showing high-grade silver-gold intercepts.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.